Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Gains from Sales and Divestitures (2022 - 2023)

Historic Gains from Sales and Divestitures for Therapeutics (LENZ) over the last 2 years, with Q3 2023 value amounting to $703035.0.

  • Therapeutics' Gains from Sales and Divestitures rose 4000.44% to $703035.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $703035.0, marking a year-over-year increase of 4000.44%. This contributed to the annual value of $553443.0 for FY2022, which is N/A changed from last year.
  • Latest data reveals that Therapeutics reported Gains from Sales and Divestitures of $703035.0 as of Q3 2023, which was up 4000.44% from $653970.0 recorded in Q2 2023.
  • Therapeutics' Gains from Sales and Divestitures' 5-year high stood at $703035.0 during Q3 2023, with a 5-year trough of $398028.0 in Q1 2022.